For Questions $13$ to $16,$ use the following information:Biotech Avenger is a small firm engaged in genetic research. It is an all$-$equity firm with $5$ million shares outstanding. The current market capitalization is $2\mathrm{.}5$ million.The firm has just announced that it will change its capital structure by issuing $0\mathrm{.}4$ million in debt and also use an existing $0\mathrm{.}6$ million in cash to repurchase existing shares.Assume perfect capital markets$\mathrm{.}13.$ Find the share price of Biotech Avenger before and after the restructure$\mathrm{.}14.$ Find the debt$-$to$-$equity ratio after the restructure$\mathrm{.}15.$ Find the number of outstanding shares repurchased in the transaction$\mathrm{.}16.$ You hold $38000$ shares of Biotech Avenger and you disagree with the decision to lever the firm. Describe how you can undo the decision.